3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma
3
Triple Negative Breast Neoplasms
2
Glioblastoma
2
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Liver Neoplasms
1
Glioma
1
Fibrolamellar hepatocellular carcinoma
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Cyclophosphamide
9
X-Rays
8
Specimen Handling
8
Phantoms, Imaging
7
fludarabine
6
Magnetic Resonance Spectroscopy
6
cabozantinib
5
Gemcitabine
5
Biopsy
5
Nuclear Medicine Department, Hospital
4
Methotrexate
4
Doxorubicin
4
fludarabine phosphate
3
Ifosfamide
3
Cisplatin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
pembrolizumab
2
palbociclib
2
olaparib
2
mifamurtide
2
larotrectinib
2
ivosidenib
2
irinotecan sucrosofate
2
ensartinib
2
atezolizumab
2
Vincristine
2
Temozolomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
poly ICLC
×
90 days
×
Clear all
No trials found.